After Celgene deal, BMS shoots up pharma market cap rankingsBristol-Myers Squibb $74 billion takeover of Celgene saw it shoot up the list of top 20 pharma companies Share XAfter Celgene deal, BMS shoots up pharma market cap rankingshttps://pharmaphorum.com/news/after-celgene-deal-bms-shoots-up-pharma-market-cap-rankings/
Australia’s CSL on the rise as profits increase 30%US operations pull in revenues Share XAustralia’s CSL on the rise as profits increase 30%https://pharmaphorum.com/news/australias-csl-rise-profits-increase-30/